Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20622| Title: | Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases? |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Aged,Antineoplastic Combined Chemotherapy Protocols/*adverse effects/therapeutic use,Bone Marrow/drug effects,Bone Marrow Diseases/*chemically induced/drug therapy,Hodgkin Disease/complications/*drug therapy,Humans,Hypogonadism/complications/*drug therapy,Male,Mechlorethamine/administration & dosage/adverse effects,Pituitary Hormone-Releasing Hormones/deficiency,Prednisone/administration & dosage/adverse effects,Procarbazine/administration & dosage/adverse effects,Testosterone/*therapeutic use,Vincristine/administration & dosage/adverse effects |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/20622 |
| ISSN: | 0098-1532 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/2664441 http://onlinelibrary.wiley.com/store/10.1002/mpo.2950170310/asset/2950170310_ftp.pdf?v=1&t=h0niod8i&s=37f7afb73cb548fe7873ba069ed4a7d3a86a6f5a |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pavlidis-1989-Is androgen substitu.pdf | 368 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
